TWISTed fibroblasts: New drivers of intestinal fibrosis in Crohn's disease

Sara Lovisa, Stefania Vetrano · 2024

Read TWISTed fibroblasts: New drivers of intestinal fibrosis in Crohn's disease by Sara Lovisa, Stefania Vetrano (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11626011.txt.

Description

Sara Lovisa and Stefania Vetrano summarize new work that names a cell type as a main driver of gut scarring in Crohn disease, in work published in 2024. Scarring narrows the gut in half or more of patients and often needs surgery, with relapse common. The cells that build scar tissue are varied and were poorly mapped.

Two recent studies agree that fibroblasts marked by two proteins are the primary scar driving population. Blocking the second protein in mice reduced scarring, and a known inhibitor of it reversed fibrosis in those models. The authors say the finding opens a path to anti scarring drugs for Crohn disease, a need that has long lacked clear targets.

Catalog record

CREATORSara Lovisa, Stefania Vetrano
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11626011

Browse the full library · About the Tower of Babel